Pfizer is tapping Blackstone for up to $1.5 billion to fund its weight-loss drug
Source ↗
👁 7
💬 0
Blackstone would be eligible for milestone payments tied to U.S. approval of monthly berobenatide, while Pfizer keeps full control
Comments (0)